Brokers Issue Forecasts for Clorox’s Q4 Earnings (NYSE:CLX)

The Clorox Company (NYSE:CLX) – Equities research analysts at Zacks Research lifted their Q4 2026 earnings estimates for Clorox in a research note issued on Monday, February 17th. Zacks Research analyst R. Department now expects that the company will earn $2.18 per share for the quarter, up from their previous estimate of $1.90. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share.

Other equities analysts also recently issued research reports about the stock. JPMorgan Chase & Co. increased their price target on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Evercore ISI increased their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. Barclays increased their price objective on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Finally, StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat, Clorox presently has an average rating of “Hold” and an average price target of $158.21.

Clorox Stock Performance

NYSE:CLX opened at $150.93 on Thursday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The company has a market cap of $18.68 billion, a P/E ratio of 41.24, a P/E/G ratio of 2.53 and a beta of 0.42. Clorox has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The firm’s 50 day moving average is $158.38 and its two-hundred day moving average is $159.74.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business earned $2.16 EPS.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Catalyst Capital Advisors LLC bought a new stake in Clorox in the 3rd quarter valued at about $54,000. Los Angeles Capital Management LLC lifted its position in Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after purchasing an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. lifted its position in Clorox by 43.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after purchasing an additional 9,037 shares during the last quarter. Natixis Advisors LLC lifted its position in Clorox by 8.3% in the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after purchasing an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in Clorox by 1.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after purchasing an additional 13,038 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.